Vincristine (generic), Oncovin, Vincasar News

Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.

Hana Biosciences , a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced data from its pivotal Phase 2 rALLy clinical trial for Marqibo for the treatment of adult acute lymphoblastic leukemia in second relapse.

Causes of Ileus There are two types of intestinal obstruction, mechanical and non-mechanical. Mechanical obstructions occur because the bowel is physically blocked and its contents can not pass the point of the obstruction.

C cells. In contrast, the level of phospho-cofilin was greatly increased in the drug-resistant cells.

More than 60% of patients with diffuse large B-cell lymphoma will be cured with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone .

BACKGROUND: The addition of rituximab to CHOP chemotherapy improves outcome in patients with diffuse large B-cell lymphoma .

Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission in relapsed/refractory aggressive and indolent non-Hodgkin's ...

A short-term partial response was followed by disease progression after 4 weeks.

However, studies at single institutions have suggested that 55 to 65 percent of such patients might be cured by third-generation regimens such as ones consisting of low-dose methotrexate with leucovorin rescue, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone ; prednisone, doxorubicin, cyclophosphamide, and etoposide, ...

Hana Biosciences today announced that the Company has entered into a Clinical Trial Agreement with the Center for Cancer Research at the National Cancer Institute for the co-development of Marqibo in refractory pediatric cancer.

In a previous study, we reported that remission was typically lost around the time l-asparaginase was discontinued.

Obesity may directly impair the efficacy of leukemia treatment, according to an animal study published online Sept.

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group protocol ALL-9 . Export The lancet oncology Amazoness Abstract BACKGROUND: A population-based cohort of children aged 1-18 years with acute lymphoblastic leukaemia was treated with a dexamethasone-based protocol .

Leukemia cells can hide in fat tissue to evade chemotherapy, which may explain why obese children with leukemia are more likely to develop chemotherapy resistance and have higher relapse rates, researchers say.

We thank Dr. Hsu and colleagues for their comments on our meta-analysis. We agree that corticosteroids play an important role in chemotherapy-induced HBV reactivation, which is why we listed corticosteroid use in a dedicated column in Table 1 of our article.

Although chemotherapy with procarbazine, lomustine and vincristine is considered to be well tolerated, side effects frequently lead to dose reduction or even discontinuation of treatment of oligodenrdroglial brain tumors.

Abstract One half of patients newly diagnosed with lymphoma are older than 60 years and a significant proportion of them older than 80 years.

Millennium: The Takeda Oncology Company today reported data from two clinical trials evaluating VELCADE based combinations for patients with non-Hodgkin's lymphoma .

An 84-year-old man presented with an isolated sensation of a lump in the back of his throat and difficulty swallowing that had developed over several months.

Yesterday Bianca had a cross-country event at her school. Now for Bianca's age group it was really just around the field area.